Research In Brief
This article was originally published in The Gray Sheet
Executive Summary
ICD benefits in women: Meta-analysis of implantable cardioverter defibrillator studies published in the July issue of HeartRhythm shows that while women and men had the same overall mortality rates, women had significantly fewer ICD interventions on rapid, sustained ventricular tachycardia or fibrillation than men, "thus suggesting a smaller impact of sudden cardiac death on overall mortality in women with dilated cardiomyopathy." Researchers led by Pasquale Santangeli, Catholic University of the Sacred Heart in Rome, reviewed five studies that enrolled 7,229 patients with dilated cardiomyopathy, including Boston Scientific's MADIT II and the landmark Sudden Cardiac Death in Heart Failure trial
You may also be interested in...
Feds Attack Medicare Fraud As One Piece Of The Geographic Variation Puzzle
Policy makers have teased out Medicare fraud as one of several contributors to the well documented problem of geographic variation in health care spending
Reimbursement In Brief
MedCAC pharmacogenomics meeting: The Medicare Evidence Development and Coverage Advisory Committee will meet Jan. 27, 2010, in Baltimore to review evidence on the impact of pharmacogenomic testing on health outcomes in cancer patients. Specifically, the panel will assess assays that might be used as a guide for certain drug treatments for breast cancer, colon cancer, chronic myelogenous leukemia or metastatic colorectal cancer. The upcoming meeting is the third in a series of MedCAC discussions held this year on evidence supporting genetic and genomic screening (1"The Gray Sheet" May 25, 2009)
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.